Ann: Appendix 4C - quarterly , page-4

Hi Coop,
What might seem disappointing is that they are still recruiting for trials so as to get data to form a submission.

Not to mention they have sales for the half year similar to a local corner store.

Will be unlikely to have any FDA approval for 2 years in my opinion.

Then the CDC another 12 months in order to sell the product.

Also cash burn will more than likely increase as trials ramp up.

Thats how I see it, hopefully for holders Iam wrong.

Regards,

PS four brokers $4.50 price target,should have their licences revoked.